Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-01

Clinical Trial Update: Colchicine for Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating colchicine for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED